EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Mitochondria-targeted therapeutic strategies in assisted reproduction: challenges and potential solutions

Raziye Melike Yildirim, Gizem Nur Sahin, Richard T Scott, Emre Seli iD

Human Reproduction · 2026

DOI: 10.1093/humrep/deag118 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Reproduction, 2026. Verfasst von Raziye Melike Yildirim und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA. Hauptthemen laut MEDLINE: Reproductive Techniques, Assisted, Mitochondria, Mitochondrial Replacement Therapy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Mitochondria are central to oocyte competence and early embryonic development, with roles that extend beyond energy production to include regulation of redox homeostasis, apoptosis and cellular aging. Mitochondrial dysfunction is increasingly recognized as a key contributor to diminished ovarian reserve, impaired embryo development, and accelerated reproductive aging. Mitochondria-targeted therapeutic strategies, including pharmacological approaches such as Coenzyme Q10, mitoquinone, resveratrol, rapamycin, and NAD+ precursors, as well as mitochondrial replacement techniques such as maternal spindle and pronuclear transfer, have shown promise in preclinical models; however, clinical outcomes remain heterogeneous and often inconclusive. This translational gap likely reflects critical limitations, including variability in therapeutic targets, suboptimal timing of intervention relative to oocyte development, and insufficiently powered or standardized clinical studies. Greater emphasis on well-defined, physiologically justified therapeutic targets, along with the use of physiologically relevant experimental systems, may improve therapeutic precision and efficacy. Rigorous evaluation of safety, particularly for interventions with pleiotropic effects or heritable consequences, remains essential. A more targeted, developmentally informed and systematically validated approach is needed to advance mitochondria-based therapies toward meaningful improvements in reproductive outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Reproductive Techniques, AssistedMitochondriaMitochondrial Replacement TherapyHumansFemaleAnimalsOocytesOvarian ReserveEmbryonic Development

Stichwörter der Autor:innen

embryo aneuploidymitochondrial dysfunctionmitochondrial replacement therapyoocyte qualityovarian reserve

Autor:innen und Institutionen

  • Department of Obstetrics, Gynecology, and Reproductive Sciences, Yale School of Medicine, New Haven, CT, USA.

ORCID-Profile: Emre Seli

Zitieren

APA

Yildirim, R. M., Sahin, G. N., Scott, R. T., & Seli, E. (2026). Mitochondria-targeted therapeutic strategies in assisted reproduction: challenges and potential solutions. Human Reproduction. https://doi.org/10.1093/humrep/deag118

Vancouver

Yildirim RM, Sahin GN, Scott RT, Seli E. Mitochondria-targeted therapeutic strategies in assisted reproduction: challenges and potential solutions. Human Reproduction. 2026. doi:10.1093/humrep/deag118

BibTeX
@article{Yildirim2026,
  author = {Yildirim, Raziye Melike and Sahin, Gizem Nur and Scott, Richard T and Seli, Emre},
  title = {Mitochondria-targeted therapeutic strategies in assisted reproduction: challenges and potential solutions},
  journal = {Human Reproduction},
  year = {2026},
  doi = {10.1093/humrep/deag118}
}
Kostenlos starten →